The Antiepileptic Drugs Market has demonstrated substantial growth, with its size reaching an estimated USD 18.21 billion in 2023. Forecasts indicate continued expansion, projecting a market value of USD 26.30 billion by 2031. This upward trend underscores the increasing prevalence of epilepsy and related disorders worldwide, coupled with advancements in drug development and treatment strategies. With a forecasted compound annual growth rate (CAGR) of 4.70% during the period from 2024 to 2031, the market is expected to witness sustained growth, driven by factors such as the introduction of novel therapies, rising awareness, and expanding healthcare infrastructure.